Related references
Note: Only part of the references are listed.Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers A Randomized, Open-Label, Two-Period, Parallel-Group, Crossover Study
Alice I. Nichols et al.
CLINICAL DRUG INVESTIGATION (2011)
Variation in GNB3 predicts response and adverse reactions to antidepressants
Robert Keers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder
Sneha Narasimhan et al.
NEUROSCIENCE LETTERS (2011)
Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample
Nader Perroud et al.
PHARMACOGENOMICS (2011)
Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project
R. Keers et al.
PHARMACOGENOMICS JOURNAL (2011)
Association of FKBP5 Polymorphisms With Suicidal Events in the Treatment of Resistant Depression in Adolescents (TORDIA) Study
David Brent et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Failure to Replicate Genetic Associations with Antidepressant Treatment Response in Duloxetine-Treated Patients
Roy H. Perlis et al.
BIOLOGICAL PSYCHIATRY (2010)
Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
Matthew J. Taylor et al.
BIOLOGICAL PSYCHIATRY (2010)
A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Holly A. Garriock et al.
BIOLOGICAL PSYCHIATRY (2010)
The pharmacogenetics of antidepressant-induced mania: a systematic review and meta-analysis
Federico M. Daray et al.
BIPOLAR DISORDERS (2010)
HTR2A gene variation is involved in antidepressant treatment response
Susanne Lucae et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine
F. Benedetti et al.
EUROPEAN PSYCHIATRY (2010)
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
Magali Noro et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response
Katharina Domschke et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder
Mei Hung Chi et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure
Yuyan Jin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine: A Secondary Analysis of 4 Studies in Major Depressive Disorder
Kasia W. Lobello et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Relation of Serotonin Transporter Genetic Variation to Efficacy of Escitalopram for Generalized Anxiety Disorder in Older Adults
Eric J. Lenze et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
M. Kato et al.
MOLECULAR PSYCHIATRY (2010)
Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain
N. V. Murthy et al.
NEUROIMAGE (2010)
HTR2A is Associated with SSRI Response in Major Depressive Disorder in a Japanese Cohort
Taro Kishi et al.
NEUROMOLECULAR MEDICINE (2010)
Antidepressants and ABCB1 Gene C3435T Functional Polymorphism: A Naturalistic Study
Patrick Menu et al.
NEUROPSYCHOBIOLOGY (2010)
Serotonin Transporter Gene Polymorphism Associated with Short-Term Treatment Response to Venlafaxine
Sang-Hyuk Lee et al.
NEUROPSYCHOBIOLOGY (2010)
Norepinephrine and Serotonin Transporter Genes: Impact on Treatment Response in Depression
Anna Baffa et al.
NEUROPSYCHOBIOLOGY (2010)
Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment
Sonja Horstmann et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders
Yan-Feng Zou et al.
NEUROSCIENCE LETTERS (2010)
TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response
Merja Viikki et al.
NEUROSCIENCE LETTERS (2010)
ABCB1 ( MDR1) polymorphisms and antidepressant response in geriatric depression
Jane E. Sarginson et al.
PHARMACOGENETICS AND GENOMICS (2010)
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response
Ming-Hsien Tsai et al.
PHARMACOGENOMICS (2010)
SLC6A4 Variation and Citalopram Response
D. A. Mrazek et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Effect of 5-HT1A Gene Polymorphisms on Antidepressant Response in Major Depressive Disorder
Masaki Kato et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Novel Sequence Variations in the Brain-Derived Neurotrophic Factor Gene and Association With Major Depression and Antidepressant Treatment Response
Julio Licinio et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression
Marcus Ising et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
National Patterns in Antidepressant Medication Treatment
Mark Olfson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder
Roy H. Perlis et al.
BIOLOGICAL PSYCHIATRY (2009)
Moderation of antidepressant response by the serotonin transporter gene
Patricia Huezo-Diaz et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Cognitive-Affective Neuroscience of Depersonalization
Dan J. Stein et al.
CNS SPECTRUMS (2009)
Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker
L. Noehr-Jensen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
Eduard Maron et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
MAOA Gene polymorphisms and response to mirtazapine in major depression
Dong-Sheng Tzeng et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients
Alessandro Serretti et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)
The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder
Alexandre de Agular Ferreira et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients
Shih-Jen Tsai et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients
Laura Mandelli et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depressive Disorder
Andrew F. Leuchter et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Pharmacogenetics of anxiolytic drugs
Arun K. Tiwari et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans
C. Dong et al.
MOLECULAR PSYCHIATRY (2009)
Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed Patients
Roy H. Perlis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project
Nader Perroud et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response
Eric J. Peters et al.
PHARMACOGENETICS AND GENOMICS (2009)
Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy
M. J. V. Wilkie et al.
PHARMACOGENOMICS JOURNAL (2009)
Genetic predictors of response to antidepressants in the GENDEP project
Rudolf Uher et al.
PHARMACOGENOMICS JOURNAL (2009)
Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response
Shih-Jen Tsai et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder
Eugene Lin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
Gonzalo Laje et al.
PSYCHIATRIC SERVICES (2009)
The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting
Francesco Benedetti et al.
PSYCHOPHARMACOLOGY (2009)
What is the genetic relationship between anxiety and depression?
John M. Hettema
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2008)
Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein
Jun-Sheng Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
The FKBP5-gene in depression and treatment response -: An association study in the sequenced treatment alternatives to relieve depression (STAR*D) cohort
Magnus Lekman et al.
BIOLOGICAL PSYCHIATRY (2008)
Serotonin transporter polymorphism and bleeding time during SSRI therapy
Dahlia M. C. Hougardy et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients
S. Horstmann et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Cannabinoid receptor 1 (CNR1) gene:: Impact on antidepressant treatment response and emotion processing in Major Depression
Katharina Domschke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran
Keizo Yoshida et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea
Misuzu Tanaka et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Rapid onset of antidepressant action: A new paradigm in the research and treatment of major depressive disorder
Rodrigo Machado-Vieira et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression
Manfred Uhr et al.
NEURON (2008)
Serotonin receptor 1A-1019C/G variant: Impact on antidepressant pharmacoresponse in melancholic depression?
B. T. Baune et al.
NEUROSCIENCE LETTERS (2008)
Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample
Eric J. Peters et al.
PLOS ONE (2008)
Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment
Mladen Vassilev Tzvetkov et al.
PHARMACOGENETICS AND GENOMICS (2008)
Genetic variants in FKBP5 affecting response to antidepressant drug treatment
Julia Kirchheiner et al.
PHARMACOGENOMICS (2008)
Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: A pilot study
Georg Nikisch et al.
PHARMACOLOGICAL RESEARCH (2008)
Pharmacogenomic biomarker information in drug labels approved by the United States Food and Drug Administration: Prevalence of related drug use
Felix W. Frueh et al.
PHARMACOTHERAPY (2008)
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
Masaki Kato et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression
Katharina Domschke et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression
Alma Mihaljevic Peles et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Antidepressant response and intolerance to SSRI is not influenced by G-protein β3 subunit gene C825T polymorphism in Japanese major depressive patients
Masaki Kato et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Serotonin transporter gene polymorphisms and sertraline response in major depression patients
Ozlem Dogan et al.
GENETIC TESTING (2008)
A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders
M. Gratacos et al.
PHARMACOGENOMICS JOURNAL (2008)
Association of the COMT val158met variant with antidepressant treatment response in major depression
Bernhard T. Baune et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients
I. Rudberg et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment
Shih-Jen Tsai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment
Sergi Papiol et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders
Sefi Kronenberg et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2007)
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein
Francesca Calabrese et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Genetic markers of suicidal ideation emerging during citalopram treatment of major depression
Gonzalo Laje et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder
Rhee-Hun Kang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Brain-derived neurotrophic factor (BDNF) gene not associated with antidepressant-induced mania
Gwyneth Zai et al.
BIPOLAR DISORDERS (2007)
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine
Keizo Yoshida et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort
Silvia Paddock et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression
Xian-Zhang Hu et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala
Lawrence P. Reagan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study
Roy H. Perlis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors
Kim Smits et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial
Damiaan Denys et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression
Andre Tadic et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Dose-dependent effects of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients
Naoki Fukui et al.
THERAPEUTIC DRUG MONITORING (2007)
Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model
Kim M. Smits et al.
CLINICAL THERAPEUTICS (2007)
Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders
Zhongchun Liu et al.
NEUROSCIENCE LETTERS (2007)
A splice site polymorphism in the G-protein β subunit influences antidepressant efficacy in depression
Murray J. V. Wilkie et al.
PHARMACOGENETICS AND GENOMICS (2007)
A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment
J. Kirchheiner et al.
PHARMACOGENOMICS JOURNAL (2007)
Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity:: Characterization of gene duplication events
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population
Byung-Joo Ham et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness
Gary M. Levin et al.
MOLECULAR DIAGNOSIS & THERAPY (2007)
Relationship between g-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression
Rhee-Hun Kang et al.
NEUROPSYCHOBIOLOGY (2007)
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression
Masaki Kato et al.
NEUROPSYCHOBIOLOGY (2007)
Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population
Won Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder
Myoung-Jin Choi et al.
BRAIN RESEARCH (2006)
Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
Jantien P. Brouwer et al.
PSYCHONEUROENDOCRINOLOGY (2006)
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report
A. John Rush et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene
Fiona M. Baumer et al.
BIOLOGICAL PSYCHIATRY (2006)
Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression
Hyeran Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders
Younger W. -Y. Yu et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine
M. E. E. Shams et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Higher 5-HTIA receptor binding potential during a major depressive episode predicts poor treatment response:: Preliminary data from a naturalistic study
Rarnin V. Parsey et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder
Murray B. Stein et al.
PSYCHOPHARMACOLOGY (2006)
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
FJ McMahon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
ABCB1 (P-Glycoprotein/MDR1) gene G2677T/A sequence variation (polymorphism):: Lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline
B Laika et al.
CLINICAL CHEMISTRY (2006)
Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies
Stacey A. Sakowski et al.
BRAIN RESEARCH (2006)
Polymorphisms of the glucocorticoid receptor gene and major depression
EFC van Rossum et al.
BIOLOGICAL PSYCHIATRY (2006)
Polymorphisms in the 5-hydroxytryptamine 2A receptor and cytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in Japanese depressed patients
Y Suzuki et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms
K Hedenmalm et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Serotonin transporter polymorphisms and side effects in antidepressant therapy - a pilot study
J Popp et al.
PHARMACOGENOMICS (2006)
Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder
E Masoliver et al.
PSYCHIATRIC GENETICS (2006)
Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder
CJ Hong et al.
PHARMACOGENOMICS JOURNAL (2006)
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients
Masaki Kato et al.
NEUROPSYCHOBIOLOGY (2006)
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene
G Perna et al.
NEUROPSYCHOPHARMACOLOGY (2005)
No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population
BJ Ham et al.
PSYCHIATRIC GENETICS (2005)
Sequence analysis of the serotonin transporter and associations with antidepressant response
JB Kraft et al.
BIOLOGICAL PSYCHIATRY (2005)
Association study of a Monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response
YWY Yu et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression
B Bondy et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder
SH Lee et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2005)
Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment
A Putzhammer et al.
PSYCHOPHARMACOLOGY (2005)
Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram
B Arias et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2005)
Amitriptyline or not, that is the question:: Pharmacogenetic testing of CYP2D6 and CYP219 identifies patients with low or high risk for side effects in amitriptyline therapy
W Steimer et al.
CLINICAL CHEMISTRY (2005)
The catechol-O-methyltransferase Val(108/158)Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression
A Szegedi et al.
PHARMACOGENOMICS JOURNAL (2005)
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression
XD Zhang et al.
NEURON (2005)
Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram
MJ Choi et al.
NEUROPSYCHOBIOLOGY (2005)
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms
K Yoshida et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up
A Serretti et al.
PHARMACOGENETICS (2004)
Investigation of serotonin-related genes in antidepressant response
EJ Peters et al.
MOLECULAR PSYCHIATRY (2004)
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders
A Serretti et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder
LK Durham et al.
PSYCHOPHARMACOLOGY (2004)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
EB Binder et al.
NATURE GENETICS (2004)
The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings
A Serretti et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans
J Licinio et al.
MOLECULAR PSYCHIATRY (2004)
Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response
S Lemonde et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting
K Grasmäder et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men
TC Baghai et al.
NEUROSCIENCE LETTERS (2004)
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression
GM Murphy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels
JPR Jacobsen et al.
BRAIN RESEARCH (2004)
The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients
Y Suzuki et al.
PHARMACOGENOMICS JOURNAL (2004)
Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders
HJ Lee et al.
PHARMACOGENOMICS JOURNAL (2004)
Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review
KM Smits et al.
MOLECULAR PSYCHIATRY (2004)
Age-dependent antidepressant pharmacogenomics:: polymorphisms of the serotonin transporter and G protein β3 subunit as predictors of response to fluoxetine and nortriptyline
PR Joyce et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study
B Arias et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Antidepressant-induced mania: an overview of current controversies
JF Goldberg et al.
BIPOLAR DISORDERS (2003)
Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine
C Charlier et al.
THERAPEUTIC DRUG MONITORING (2003)
Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response
SJ Tsai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption
M Uhr et al.
BIOLOGICAL PSYCHIATRY (2003)
Pharmacogenetics of antidepressant medication intolerance
GM Murphy et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
D2 dopamine receptor gene polymorphism: paroxetine and social functioning in posttraumatic stress disorder
BR Lawford et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
T102C and-1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder
S Tot et al.
EUROPEAN PSYCHIATRY (2003)
Beta-1-adrenergic receptor gene in major depression:: Influence on antidepressant treatment response
P Zill et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET
K Shioe et al.
SYNAPSE (2003)
SSRIs antidepressant activity is influenced by Gβ3 variants
A Serretti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
MF Egan et al.
CELL (2003)
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment
RH Perlis et al.
BIOLOGICAL PSYCHIATRY (2003)
Monoamine oxidase a gene polymorphism, 5-HT2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine
K Yoshida et al.
NEUROPSYCHOBIOLOGY (2003)
Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism
A Rousseva et al.
PHARMACOGENOMICS JOURNAL (2003)
Monoamine oxidase: A gene poly polymorphism and antidepressant orphism, tryptophan hydroxylase gene response to fluvoxamine in Japanese patients with major depressive disorder
K Yoshida et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment
H Takahashi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2002)
A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine
K Ito et al.
PSYCHIATRY RESEARCH (2002)
Signaling networks in the pathophysiology and treatment of mood disorders
TD Gould et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)
Moclobemide response in depressed patients:: Association study with a functional polymorphism in the monoamine oxidase A promoter
DJ Müller et al.
PHARMACOPSYCHIATRY (2002)
Clinical applications of pharmacogenetics in psychiatry
S Staddon et al.
PSYCHOPHARMACOLOGY (2002)
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients
K Yoshida et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Molecular genetics of CYP2D6:: Clinical relevance with focus on psychotropic drugs
L Bertilsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Generalized anxiety disorder: Prevalence, burden, and cost to society
HU Wittchen
DEPRESSION AND ANXIETY (2002)
Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity
C Cusin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders
H Kunugi et al.
JOURNAL OF NEURAL TRANSMISSION (2002)
No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors
A Serretti et al.
PSYCHIATRY RESEARCH (2001)
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
A Serretti et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression
R Zanardi et al.
BIOLOGICAL PSYCHIATRY (2001)
Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity
A Serretti et al.
MOLECULAR PSYCHIATRY (2001)
No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism
M Willeit et al.
BIOLOGICAL PSYCHIATRY (2001)
The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder - Preliminary findings
E Mundo et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Serotonin-2A-receptor and -transporter polymorphisms:: lack of association in patients with major depression
C Minov et al.
NEUROSCIENCE LETTERS (2001)
Association study of the 5-HT6 receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders
WH Wu et al.
NEUROPSYCHOBIOLOGY (2001)
Association analysis of a functional G protein beta 3 subunit gene polymorphism (C825T) in mood disorders
CN Lin et al.
NEUROPSYCHOBIOLOGY (2001)
Allelic variation, in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
BG Pollock et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Evidence for an association between a G-protein β3-gene variant with depression and response to antidepressant treatment
P Zill et al.
NEUROREPORT (2000)
Venlafaxine serum levels and CYP2D6 genotype
AH Veefkind et al.
THERAPEUTIC DRUG MONITORING (2000)
Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr1a P-glycoprotein gene disruption
M Uhr et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene
R Zanardi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Serotonin transporter gene polymorphism and antidepressant response
DK Kim et al.
NEUROREPORT (2000)
Share Paper
